Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol plus Oxytocin for Postpartum Hemorrhage Prevention
NCT05245227Phase 3Recruiting
- Sponsor
- Stony Brook University
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of misoprostol in postpartum hemorrhage (PPH), sponsored by Stony Brook University. Started Jan 2025; status: recruiting.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT05245227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05245227.